0001213900-22-074030.txt : 20221121 0001213900-22-074030.hdr.sgml : 20221121 20221121085118 ACCESSION NUMBER: 0001213900-22-074030 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221118 FILED AS OF DATE: 20221121 DATE AS OF CHANGE: 20221121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jermasek Douglas CENTRAL INDEX KEY: 0001955273 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40582 FILM NUMBER: 221403615 MAIL ADDRESS: STREET 1: 4300 EL CAMINO REAL STREET 2: SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4300 EL CAMINO REAL, SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 4300 EL CAMINO REAL, SUITE 210 CITY: LOS ALTOS STATE: CA ZIP: 94022 3 1 ownership.xml OWNERSHIP DOCUMENT X0206 3 2022-11-18 0 0001766140 Unicycive Therapeutics, Inc. UNCY 0001955273 Jermasek Douglas 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 0 0 0 1 EVP of Corporate Strategy Common Stock 70400 D Stock Options 2.56 2031-10-20 Common Stock 100000 D 25,000 options vested on October 20, 2022 and the remainder vest over 36 months after the initial vesting. /s/ Douglas Jermasek 2022-11-21